Netnoids Rx Laboratories

Spanios, formerly known as Netnoids Rx Laboratories, is a Houston-based biotechnology company specializing in the development of patient-derived tumoroids (PDTs) to accelerate oncology drug discovery. The company's proprietary COMPASS platform recreates the human tumor microenvironment (TME) ex-vivo, including functional immunity and physiological oxygenation, providing a more predictive alternative to traditional animal models. Spanios operates under a "hub and spoke" business model, offering specialized laboratory services and biobanked models to pharmaceutical partners while simultaneously advancing its own internal pipeline of targeted cancer therapeutics. By focusing on rare and difficult-to-treat solid tumors, the company aims to de-risk clinical trials and enable precision medicine through high-fidelity preclinical validation.